Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multicomponent therapeutics for networked systems.

Curtis T Keith1, Alexis A Borisy, Brent R Stockwell

  • 1CombinatoRx, Inc., 650 Albany Street, Boston, Massachusetts 02118, USA.

Nature Reviews. Drug Discovery
|February 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging roles of ferroptosis in modulating the immune landscape of glial tumours.

Nature cell biology·2026
Same author

MiR-940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

GPX4 regulates lipid peroxidation and ferroptosis of stored red blood cells.

Blood. Red cells & iron·2026
Same author

Dissecting Polypharmacology in Phenotypic Screening to Resolve Ferroptotic and Necrotic Cell-Death Mechanisms.

ACS medicinal chemistry letters·2026
Same author

When Pathways Converge: Iron, Lipid Peroxidation, and α-Synuclein in Ferroptosis-Driven Dopaminergic Neurodegeneration.

Journal of neurochemistry·2026
Same author

Ferroptosis as an approach to leverage cancer metabolism.

Trends in cell biology·2026
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Discovering effective drug combinations early in the drug discovery process can lead to more potent therapeutic regimens. A systems approach aids in understanding how these multi-ingredient drugs work.

Area of Science:

  • Pharmacology and Drug Discovery
  • Systems Biology
  • Medicinal Chemistry

Background:

  • Combination therapy is prevalent in clinical practice, yet drug discovery predominantly focuses on single agents.
  • The optimization of single-molecule drugs often overlooks the potential of synergistic therapeutic combinations.

Purpose of the Study:

  • To advocate for a shift towards early-stage identification and optimization of multi-component drug regimens.
  • To highlight the utility of a systems perspective in understanding combination drug mechanisms.

Main Methods:

  • Review of current drug discovery paradigms.
  • Conceptual framework for systems-based analysis of drug combinations.

Main Results:

Related Experiment Videos

  • Focusing on drug combinations early can yield more effective therapeutic strategies.
  • Systems biology approaches provide deeper insights into the mechanisms of action for combination therapies.
  • Conclusions:

    • Integrating combination drug discovery into early stages is crucial for developing superior treatments.
    • A systems perspective is essential for unlocking the full potential of multi-ingredient therapeutic regimens.